Schedule 13G ownership disclosure

Denali Therapeutics Inc

Security class unavailable · CUSIP: 24823R105

Event date: Unavailable

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
7,590,247
Percent of class
7.9000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001088875-20-000010
Form type
SC 13G/A
Filer
BAILLIE GIFFORD & CO
CIK
CIK 1088875
Filed
Jan 16, 2020
Reporting period
—
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub